Navigation Links
Children’s Tumor Foundation Recognizes Neurofibromatosis Awareness Month with “I Know a Fighter” Campaign

The Children’s Tumor Foundation announced its annual month-long campaign to raise awareness about neurofibromatosis (NF), a genetic disorder that causes tumors to grow on nerves throughout the body. It affects 1 in 3,000 people of all populations; there is currently no treatment or cure.

Through numerous community events held during the month of May, as well as online activities, Neurofibromatosis Awareness Month and “I Know a Fighter” aim to draw attention to the inspirational and remarkable stories of those living with NF, who are fighters in every sense of the word. A new part of the initiative this year will be “Born a Fighter,” a component that will empower those living with NF to acknowledge their own strength and resilience. The campaign will take place across multiple platforms and include a heavy social media presence centered on those fighting NF and those who support them in their fight.

There are multiple ways to get involved:

  • Shine a Light on NF - Over 100 buildings, bridges and monuments (including Niagara Falls and the John F. Kennedy Airport Air Traffic Control Tower) around the world will light up blue and green for NF Awareness Month. This year, CTF aligned efforts with the Neuro Foundation, a national NF charity in the U.K., to extend the reach globally. Visit for a complete schedule and tools to use to approach landmarks in your community.
  • Enter the 'Picture a World Without NF' photo contest. Take a photograph with any item that shows the CTF or End NF logo. Express yourself and show the world that, no matter where you are, who you are with, or what you are doing you’re fighting for a world without neurofibromatosis.
  • Visit the Children’s Tumor Foundation events calendar for a complete schedule of NF Walks, NF Endurance events, Racing4Research races, and local community fundraisers taking place all across the country to raise money to fund NF research and recognize the positive spirit and resolve of local NF Heroes and their families.
  • Follow the Children’s Tumor Foundation (@childrenstumor) on Facebook, Twitter, Instagram, and Youtube for more NF Heroes and stories about how the community is working to End NF.
  • Look for shopping carts embellished with NF awareness messages in over 4,000 supermarkets across the country, donated by News America Marketing. Take a photo, post it online, and tag @childrenstumor and #EndNF.
  • Purchase exclusive merchandise with “I Know a Fighter,” “Born a Fighter,” and End NF imagery, and support the efforts of the Children’s Tumor Foundation.

“NF Awareness Month is a unique time that exemplifies the determination of the NF community, a resolve to never give up our fight,” said Annette Bakker, PhD, Children’s Tumor Foundation President and Chief Scientific Officer. “Because NF manifests itself in a number of ways, we need many ways to fight it, and that includes these fundraising and awareness campaigns that make it even easier to connect, understand and educate about neurofibromatosis.”

Throughout the month of May, for every dollar donated to CTF, a matching dollar will be donated to NF clinic initiatives in honor and memory of Sherri Silesky, up to $75,000. Sherri demonstrated tremendous strength and power of spirit, often sprinkled with her wonderful sense of humor. Our thanks go to the Silesky family for continuing Sherri’s fight to end NF through this generous matching gift.

The Children's Tumor Foundation is committed to finding effective treatments for the millions of people worldwide living with neurofibromatosis. In addition to benefitting those who live with NF, this research is shedding new light on several forms of cancer, brain tumors, bone abnormalities, and learning disabilities, ultimately benefiting the broader community. To learn more, visit

About Children’s Tumor Foundation
The Children's Tumor Foundation is a 501(c)(3) not-for-profit organization dedicated to finding effective treatments for the millions of people worldwide living with neurofibromatosis (NF), a term for three distinct disorders: NF1, NF2, and schwannomatosis. NF causes tumors to grow on nerves throughout the body and may lead to blindness, deafness, learning disabilities, disfigurement, bone abnormalities, disabling pain, and cancer. NF affects one in every 3,000 people, more than cystic fibrosis, Duchenne muscular dystrophy, and Huntington’s disease combined. The Children’s Tumor Foundation funds critical research into neurofibromatosis. In addition to benefiting those who live with NF, this research is shedding new light on several forms of cancer, brain tumors, bone abnormalities, and learning disabilities, ultimately benefiting the broader community. For more information, please visit

Read the full story at

Source: PRWeb
Copyright©2016 Vocus, Inc.
All rights reserved

Related biology technology :

1. Svigals+Partners Announces Completion of Innovative Facility for Children’s Brain Research at UConn
2. Probiotics for Eczema Leader Announces New Developments in Using Probiotics for Children’s Eczema Relief
3. LIVE Twitter Chat Featuring Next-Generation Sequencing Expert from The Children’s Hospital of Philadelphia
4. 7 SynCardia Certified Centers Honored Among “Best Children’s Hospitals” for Cardiology and Heart Surgery by U.S. News & World Report
5. How to Treat Children’s Acne, New Tips for Parents by Probiotic Action Acne Cream
6. Probiotic Action Shares their New ‘Acne Tip Sheet” for Parents on Treating Children’s Acne with Insight from WebMD
7. Cell Signaling Technology Releases Four Monoclonal Antibodies for Immunometabolism and Tumor Immunology Research
8. BioGenex Will Introduce Fully Integrated miRNA-ISH System for Tumor Diagnosis and Clinical Research at the USCAP Annual Meeting in Seattle, WA
9. BioGenex Launches the Integrated eFISHiency System for the Analysis of Solid Tumors and Hematological Malignancies with Streamlined & Simplified Protocol
10. One Million Solutions in Health™ Announces a Signature Square™ Event for a Unique Tumor-Associated Antigen for Cancer Vaccine
11. DNAtrixs Oncolytic Immunotherapy, DNX-2401, Awarded EU Orphan Medicine Designation for Treating Malignant Brain Tumors
Post Your Comments:
(Date:10/10/2017)... International research firm Parks Associates announced today that ... TMA 2017 Annual Meeting , October 11 in Scottsdale, ... security market and how smart safety and security products impact the competitive ... Parks Associates: Smart Home Devices: Main ... "The residential security market has experienced continued ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM ... firm for the life sciences and healthcare industries, announces a presentation by Subbu ... , The presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a ...
(Date:10/9/2017)... 9, 2017  BioTech Holdings announced today identification ... its ProCell stem cell therapy prevents limb loss ... Company, demonstrated that treatment with ProCell resulted in ... as compared to standard bone marrow stem cell ... in reduction of therapeutic effect.  ...
(Date:10/9/2017)... ... , ... At its national board meeting in North Carolina, ARCS® Foundation ... of Physics and Astronomy, has been selected for membership in ARCS Alumni Hall ... 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of ...
Breaking Biology Technology:
(Date:5/16/2017)... DALLAS , May 16, 2017   ... for health organizations, and MD EMR Systems ... certified development partner for GE, have established a ... Patient Portal product and the GE Centricity™ products, ... Centricity EMR. These new integrations ...
(Date:4/24/2017)... -- Janice Kephart , former 9/11 Commission ... LLP (IdSP) , today issues the following statement: ... 6, 2017 Executive Order: Protecting the Nation ... instilled with greater confidence, enabling the reactivation of ... are suspended by until at least July 2017). ...
(Date:4/18/2017)... a global expert in SoC-based imaging and computing solutions, has developed ... the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® , ... showcased during the upcoming Medtec Japan at Tokyo Big Sight April ... Vegas Convention Center April 24-27. ... Click here for an image of the M820 ...
Breaking Biology News(10 mins):